The Myopia Exchange
Dr Kate Gifford, a global authority on managing childhood myopia (short-sightedness) in clinical practice, discusses the latest myopia research and clinical techniques with experts from around the world.
Episodes
Myopia SOS with Prof Ian Flitcroft - Episode 3 - Screens, simple details and seagulls
Myopia SOS! Dr Kate Gifford and Professor Ian Flitcroft are back with advice as your Agony Aunt and Agony Uncle, in part three of this six-part series. Coming from the southern and northern hemispheres are an optometrist and an ophthalmologist, here to help you with your curly clinical cases in myopia management. Send us your struggles using the email address podcast@myopiaprofile.com and we’ll sh
Myopia SOS with Prof Ian Flitcroft - Episode 2 - Stride into the water
Myopia SOS! Advice from your Agony Aunt Dr Kate Gifford (optometrist), and Agony Uncle Professor Ian Flitcroft (ophthalmologist), helps you tackle the daily realities of myopia management, especially when patients don’t fit the easy mould. In part two of this six part series, Kate and Ian chat across the seas about myopia research and curly clinical cases, to help you achieve smooth sailing in pra
Myopia SOS with Prof Ian Flitcroft - Episode 1 - Off the naughty step
Myopia SOS! In the first of this six part series, join your 'agony aunt' Dr. Kate Gifford, an optometrist, researcher, and co-founder of Myopia Profile, and 'agony uncle' Professor Ian Flitcroft, a distinguished paediatric ophthalmologist and co-founder of Ocumetra, as they tackle your burning questions on myopia management. In British vernacular, an Agony Aunt or Uncle is some
Atropine, Engaging With Science And Responsible Practice – With Prof Karla Zadnik
Professor Karla Zadnik, Dean of the Ohio State University College of Optometry in the USA, guides us through a variety of fascinating topics. In her capacity as Principal Investigator of the Childhood Atropine for Myopia Progression (CHAMP) study, Karla explains this multi-site, four year clinical trial which is investigating two proprietary formulations manufactured by US-based specialty pharmace
What’s next for the International Myopia Institute? – with Dr Monica Jong
Dr Monica Jong, Executive Director of the International Myopia Institute, founded by the Brien Holden Vision Institute, tells us all about the IMI’s big plans for 2020. With the landmark publication of the seven IMI White Paper reports almost a year ago now, we discuss the impact of these reports so far and all of the resources available on the IMI website www.myopiainstitute.org including summari
Myopia Management in Practice – with Philip Cheng
Philip Cheng, well-known clinical optometrist from Melbourne, Australia and prolific contributor to the Myopia Profile Facebook group, takes us through the twists and turns of myopia management in practice. Philip founded his greenfield independent practice over three years ago with a near-exclusive focus on myopia management, and in this podcast we discuss how he made the leap to establishing and
More on 0.01% atropine treatment for myopia control - with Prof Mark Bullimore
Professor Mark Bullimore of the University of Houston, Texas USA, tells us more on the complex topic of 0.01% atropine, including its stability as a compound, and takes us on a short journey through chemistry explaining how current studies are using novel formulations to address this issue. Have you heard of ‘heavy water’? I hadn’t, until now! Mark advocates for you to ‘be the doctor’, using the s
What MiSight FDA approval means to eye care practitioners - with Prof Lyndon Jones & Prof Debbie Jones
Lyndon and Debbie Jones from the Centre for Ocular Research and Education and University of Waterloo, Canada, highlight the impact that FDA approval for CooperVision MiSight myopia control contact lens has for eye care practice in the US, and across the world. How does MiSight and the FDA approval fit within the whole ecosystem of myopia control? We cover aspects from contact lens fitting and safe
Atropine 0.01% for myopia management - with Prof James Loughman
Professor James Loughman from Technological University Dublin, and the Centre for Eye Research Ireland, challenges us to think differently about low dose atropine. What are we actually getting in the bottle? How should we approach atropine usage in practice? What will future research tell us? The message on 0.01% atropine is complex and perhaps not what you expect.
IMI definitions report paper with Prof Ian Flitcroft
Kate Gifford chats to Professor Ian Flitcroft about the International Myopia Institute (IMI) paper on Defining and Classifying Myopia, of which he was the lead author. Topics include why we need to define myopia for clinical, epidemiological and research reasons; grading systems for structural complications of myopia; why the refractive definition doesn't specifically require cycloplegia and
Progressive vs bifocal spectacles - which is best
Are progressive addition lenses and bifocals created equal for myopia control? How should we pick which lens type to prescribe, and what's on the horizon for our non-contact lens wearing young myopes?
Recommended
1000x
1001 Classic Short Stories & Tales
1001raah | هزار و یک راه
1001 Sherlock Holmes Stories & The Best of Sir Arthur Conan Doyle
1001 Songs That Make You Want To Die
100 Famous Dogs
#100MasterCoaches with Mel Leow, MCC
100% Mixtape Podcast
100 With The Hunter's
10-41: A UCSO Podcast
108.3 WGKSRADIO DEEP HOUSE PARTY
10 at a Time
